CERS2 and hepatocellular carcinoma: Using the KM plotter database including 118 tumor samples in HCC patients (P = 0.018, Fig. 2D), Kaplan–Meier survival curves revealed that liver cancer patients with lower LASS2 expression had significantly reduced overall survival.